# Arcutis Biotherapeutics, Inc.: filings

ARQT · Nasdaq · CIK 1787306 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arqt.md) · [Financials](/companies/arqt/financials.md) · [Filings](/companies/arqt/filings.md) · [Insiders](/companies/arqt/insiders.md)

## Reports and events: 133 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 393, 144 154, 8-K 72, 3 31, 10-Q 20, SC 13D/A 15, 4/A 14, SC 13G/A 14, UPLOAD 11, 424B5 10, CORRESP 10, SC 13G 10, S-8 8, SCHEDULE 13G/A 8, 10-K 7, DEF 14A 6, DEFA14A 6, 10-Q/A 3, 5 3, ARS 3, DRS/A 3, EFFECT 3, SC 13D 3, 10-K/A 2, 3/A 2, 424B4 2, DRS 2, DRSLTR 2, S-1 2, S-3ASR 2, SC TO-I/A 2, SEC STAFF LETTER 2, 144/A 1, 8-A12B 1, 8-K/A 1, CERT 1, D 1, S-1/A 1, S-1MEF 1, S-3 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:21 ET | [10-Q](/filings/0001787306-26-000051.md) | Quarterly report, period 2026-06-30 | 0001787306-26-000051 |
| 2026-08-05 | 16:14 ET | [8-K](/filings/0001787306-26-000049.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001787306-26-000049 |
| 2026-07-16 | 16:25 ET | [8-K](/filings/0001628280-26-048469.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048469 |
| 2026-06-09 | 16:05 ET | [8-K](/filings/0001628280-26-041883.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-041883 |
| 2026-05-06 | 16:06 ET | [10-Q](/filings/0001787306-26-000040.md) | Quarterly report, period 2026-03-31 | 0001787306-26-000040 |
| 2026-05-06 | 16:03 ET | [8-K](/filings/0001787306-26-000039.md) | 9.01 Financial statements and exhibits | 0001787306-26-000039 |
| 2026-04-21 | 16:38 ET | [DEF 14A](/filings/0001787306-26-000028.md) | Proxy statement, period 2026-04-21 | 0001787306-26-000028 |
| 2026-02-25 | 16:07 ET | [10-K](/filings/0001787306-26-000018.md) | Annual report, period 2025-12-31 | 0001787306-26-000018 |
| 2026-02-25 | 16:04 ET | [8-K](/filings/0001787306-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-26-000017 |
| 2025-12-08 | 16:28 ET | [8-K](/filings/0001787306-25-000147.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-25-000147 |
| 2025-10-28 | 08:38 ET | [10-Q](/filings/0001787306-25-000144.md) | Quarterly report, period 2025-09-30 | 0001787306-25-000144 |
| 2025-10-28 | 08:32 ET | [8-K](/filings/0001787306-25-000142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000142 |
| 2025-08-20 | 17:19 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022498.md) | Ownership report, active investor, amended | 0001415889-25-022498 |
| 2025-08-06 | 16:15 ET | [10-Q](/filings/0001787306-25-000124.md) | Quarterly report, period 2025-06-30 | 0001787306-25-000124 |
| 2025-08-06 | 16:08 ET | [8-K](/filings/0001787306-25-000122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000122 |
| 2025-06-17 | 16:52 ET | [8-K](/filings/0001787306-25-000096.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001787306-25-000096 |
| 2025-05-06 | 16:02 ET | [10-Q](/filings/0001787306-25-000092.md) | Quarterly report, period 2025-03-31 | 0001787306-25-000092 |
| 2025-05-06 | 16:01 ET | [8-K](/filings/0001787306-25-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000091 |
| 2025-04-29 | 16:33 ET | [DEF 14A](/filings/0001787306-25-000069.md) | Proxy statement, period 2025-06-12 | 0001787306-25-000069 |
| 2025-04-10 | 17:15 ET | [8-K](/filings/0001787306-25-000058.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-25-000058 |
| 2025-02-25 | 16:04 ET | [10-K](/filings/0001787306-25-000029.md) | Annual report, period 2024-12-31 | 0001787306-25-000029 |
| 2025-02-25 | 16:02 ET | [8-K](/filings/0001787306-25-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000028 |
| 2025-01-13 | 07:33 ET | [8-K](/filings/0001787306-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000004 |
| 2024-11-06 | 16:07 ET | [10-Q](/filings/0001787306-24-000153.md) | Quarterly report, period 2024-09-30 | 0001787306-24-000153 |
| 2024-11-06 | 16:04 ET | [8-K](/filings/0001787306-24-000151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000151 |
| 2024-08-14 | 16:12 ET | [10-Q](/filings/0001787306-24-000124.md) | Quarterly report, period 2024-06-30 | 0001787306-24-000124 |
| 2024-08-14 | 16:03 ET | [8-K](/filings/0001787306-24-000122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000122 |
| 2024-07-24 | 16:10 ET | [10-Q/A](/filings/0001193125-24-183778.md) | Quarterly report, amended, period 2024-03-31 | 0001193125-24-183778 |
| 2024-06-18 | 16:47 ET | [8-K](/filings/0001787306-24-000090.md) | 5.07 Shareholder vote results | 0001787306-24-000090 |
| 2024-05-14 | 16:08 ET | [10-Q](/filings/0001787306-24-000079.md) | Quarterly report, period 2024-03-31 | 0001787306-24-000079 |
| 2024-05-14 | 16:06 ET | [8-K](/filings/0001787306-24-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000078 |
| 2024-04-26 | 16:31 ET | [DEF 14A](/filings/0001787306-24-000061.md) | Proxy statement, period 2024-04-26 | 0001787306-24-000061 |
| 2024-04-10 | 16:15 ET | [8-K](/filings/0001787306-24-000046.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-24-000046 |
| 2024-03-06 | 12:40 ET | [SC 13D/A](/filings/0001193125-24-060422.md) | Ownership report, active investor, amended | 0001193125-24-060422 |
| 2024-03-04 | 16:10 ET | [8-K](/filings/0001628280-24-008496.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-008496 |
| 2024-02-28 | 16:10 ET | [8-K](/filings/0001628280-24-007586.md) | 1.01 Entry into a material agreement | 0001628280-24-007586 |
| 2024-02-27 | 07:48 ET | [10-K](/filings/0001787306-24-000031.md) | Annual report, period 2023-12-31 | 0001787306-24-000031 |
| 2024-02-27 | 07:44 ET | [8-K](/filings/0001787306-24-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000029 |
| 2024-02-15 | 16:20 ET | [8-K](/filings/0001628280-24-005061.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-005061 |
| 2024-01-11 | 16:01 ET | [8-K](/filings/0001628280-24-001150.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-001150 |
| 2023-12-18 | 06:33 ET | [8-K](/filings/0001787306-23-000132.md) | 8.01 Other events | 0001787306-23-000132 |
| 2023-11-03 | 07:36 ET | [10-Q](/filings/0001787306-23-000124.md) | Quarterly report, period 2023-09-30 | 0001787306-23-000124 |
| 2023-11-03 | 07:32 ET | [8-K](/filings/0001787306-23-000122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-23-000122 |
| 2023-10-26 | 16:11 ET | [SC 13D/A](/filings/0001193125-23-264081.md) | Ownership report, active investor, amended | 0001193125-23-264081 |
| 2023-10-23 | 16:25 ET | [8-K](/filings/0001628280-23-034917.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034917 |
| 2023-10-19 | 16:02 ET | [8-K](/filings/0001628280-23-034688.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034688 |
| 2023-09-27 | 16:30 ET | [8-K](/filings/0001787306-23-000109.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-23-000109 |
| 2023-09-15 | 16:09 ET | [10-Q/A](/filings/0001787306-23-000106.md) | Quarterly report, amended, period 2023-06-30 | 0001787306-23-000106 |
| 2023-09-15 | 16:08 ET | [10-Q/A](/filings/0001787306-23-000105.md) | Quarterly report, amended, period 2023-03-31 | 0001787306-23-000105 |
| 2023-09-15 | 16:07 ET | [10-K/A](/filings/0001787306-23-000103.md) | Annual report, amended, period 2022-12-31 | 0001787306-23-000103 |

Page 1 of 3. [Older](/companies/arqt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:04 ET. No prices; not investment advice.